The Influence of Shc Proteins on Life Span in Mice by J.J. Ramsey et al.
Page 1 of 9
Journals of Gerontology: MEDICAL SCIENCES
Cite journal as: J Gerontol A Biol Sci Med Sci
doi:10.1093/gerona/glt198
© The Author 2013. Published by Oxford University Press on behalf of The Gerontological Society of America. 
All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
The Influence of Shc Proteins on Life Span in Mice
Jon J. Ramsey,1 Dianna Tran,1 Marco Giorgio,2 Stephen M. Griffey,3 Amanda Koehne,3 Steven T. Laing,3 
Sandra L. Taylor,4 Kyoungmi Kim,4 Gino A. Cortopassi,1 K. C. Kent Lloyd,5 Kevork Hagopian,1  
Alexey A. Tomilov,1 Enrica Migliaccio,2 Pier Giuseppe Pelicci,2 and Roger B. McDonald6
1Department of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis.
2Deparment of Experimental Oncology, European Institute of Oncology, Milan, Italy.
3Comparative Pathology Laboratory, School of Veterinary Medicine, 
4Department of Public Health Sciences, 
5Department of Surgery, School of Medicine, and 
6Department of Nutrition, University of California, Davis.
Address correspondence to Jon Ramsey, PhD, Department of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, 
1089 Vet Med Drive – VM3B, Davis, CA 95616. Email: jjramsey@ucdavis.edu
The signaling molecule p66Shc is often described as a longevity protein. This conclusion is based on a single life span 
study that used a small number of mice. The purpose of the present studies was to measure life span in a sufficient number 
of mice to determine if longevity is altered in mice with decreased Shc levels (ShcKO). Studies were completed at UC 
Davis and the European Institute of Oncology (EIO). At UC Davis, male C57BL/6J WT and ShcKO mice were fed 5% 
or 40% calorie-restricted (CR) diets. In the 5% CR group, there was no difference in survival curves between genotypes. 
There was also no difference between genotypes in prevalence of neoplasms or other measures of end-of-life pathol-
ogy. At 40% calorie restriction group, 70th percentile survival was increased in ShcKO, while there were no differences 
between genotypes in median or subsequent life span measures. At EIO, there was no increase in life span in ShcKO male 
or female mice on C57BL/6J, 129Sv, or hybrid C57BL/6J-129Sv backgrounds. These studies indicate that p66Shc is not 
a longevity protein. However, additional studies are needed to determine the extent to which Shc proteins may influence 
the onset and severity of specific age-related diseases.
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THE signaling molecule p66Shc is frequently described as a longevity protein. The Shc locus encodes three 
adaptor proteins (p46Shc, p52Shc, and p66Shc) that are 
involved in transmitting signals from growth factor recep-
tors (1). There is evidence that p66Shc participates in path-
ways that influence oxidative stress and apoptosis (2–5), 
and that cells lacking p66Shc are resistant to oxidative stress 
(3). However, the primary reason for linking p66Shc with 
longevity is a study in 1999, which found that life span 
was increased in p66Shc knockout compared with wild-type 
(WT) mice (3). It has recently been shown that the lev-
els of p46Shc and p52Shc are also decreased in liver, mus-
cle, and other tissues in these p66Shc knockout mice (6). 
Thus, these mice (we refer to as ShcKO) provide a model 
of overall decreases in Shc protein levels in multiple tis-
sues. Although the initial longevity study is widely cited 
to support a role for p66Shc as a life span determinant, there 
are clear limitations to this study that need to be consid-
ered. First, the study was completed with a small num-
ber of animals (n = 15 ShcKO and n  =  14 WT) and the 
WT mice used in this study did not have particularly long 
median (761 days) or maximum  (~850 days) life spans (3). 
Second, the published manuscript did not provide details 
about animal husbandry, diet, housing conditions, health 
surveillance, or criteria for euthanasia, which can to vary-
ing extent influence life span. Third, no end-of-life pathol-
ogy data were presented. Therefore, additional studies are 
needed to determine more thoroughly the influence of Shc 
proteins on life span.
In addition to the role Shc plays in oxidative stress 
(reviewed in (7)), there is accumulating evidence that Shc 
proteins also play an important role in metabolism. The 
activities of enzymes involved in β-oxidation and ketone 
body metabolism are increased in ShcKO compared with 
WT mice (8). Also, it has been shown that glucose toler-
ance and insulin sensitivity are increased in ShcKO versus 
WT mice (6). These metabolic changes are similar to those 
observed in calorie-restricted (CR) animals, and this has led 
to speculation that Shc proteins may play a role in the adap-
tation to CR. However, little is known about the interaction 
between CR and Shc proteins and no long-term studies have 
been completed to investigate life span in CR ShcKO mice.
The purpose of the present study was to complete life 
span studies in a sufficient number of animals to determine 
thoroughly the extent to which longevity and end-of-life 
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study was to determine the influence of calorie restriction 
on life span in these animals.
Materials and Methods
Animal Husbandry, University of California – Davis (UCD)
ShcKO mice were provided by Dr. Pier Giuseppe 
Pelicci (European Institute of Oncology, Milan, Italy) 
and used to establish a breeding colony at UC Davis. 
The breeding stocks were backcrossed onto C57BL/6J 
mice to full congenic status. Heterozygous ShcKO mice 
were mated to produce the homozygous ShcKO, and WT 
mice used for the study. At 1–2 months of age, the mice 
were singly housed in polycarbonate cages placed within 
positive pressure, HEPA filtered units. All mice were pro-
vided continuous access to water and LM-485 diet (7012 
Teklad, Harlan Laboratories, Madison, WI). The mice 
were housed in a vivarium maintained at 22°C–24°C and 
40%–60% relative humidity with a 12-hour light/12-hour 
dark cycle. All experimental procedures were approved by 
the University of California Institutional Animal Care and 
Use Committee.
Beginning at 3  months of age, daily food intake was 
measured in a subset of mice. Food intake was determined 
by collecting and weighing all food remaining in the food 
hopper and cage at the same time each day. At 4 months of 
age, the mice were randomly divided into four groups (n = 
50 per group): 5% CR WT, 5% CR ShcKO, 40% CR WT, 
and 40% CR KO. The control groups were maintained on 
5% CR to prevent excessive weight gain and obesity in 
these animals. Food intake measures from 3 to 4 months of 
age were used to determine the initial amount of LM-485 
diet given to the mice. Food intake measures were contin-
ued through 18  months of age in a group of mice (n = 5 
per genotype) allowed free choice consumption of food. 
Food intake in the CR groups was adjusted if changes in 
food intake were observed in the ad libitum fed mice. The 
daily food allotment given at 18 months of age was main-
tained until the end of the study. There were no differences 
in ad libitum food intake between the WT and ShcKO mice 
(Supplementary Figure 1), and thus both genotypes were 
given equal amounts of food for the duration of the study. 
One 5% CR WT mouse was dropped from the study and its 
data excluded from analysis because an animal husbandry 
error resulted in this mouse being fed a 40% CR diet for 
several weeks.
The mice were given fresh food daily and all animals 
were weighed weekly. Health checks were completed on 
the mice at least once per day. No other procedures were 
conducted on the mice in this study. The animals were 
allowed to live out their natural life span, and mice were 
only euthanized if they were moribund. Mice were consid-
ered moribund if they were unable to eat or drink, exhib-
ited nonresponsiveness to an external stimulus (failure to 
move when gently prodded), or developed an ulcerated or 
bleeding tumor. Any animals that were euthanized or found 
dead in their cage were collected, their body cavities were 
opened, and the carcasses were placed in 10% neutral-
buffered formalin solution and transported to the UC Davis 
Comparative Pathology Laboratory for necropsy and deter-
mination of cause of death. Date of death was recorded and 
used to calculate life span.
Sentinel mice were housed on the same racks as the study 
animals and were exposed to bedding from the study ani-
mals on a weekly basis. Sentinels were euthanized every 
3 months for health screens, including aerobic cultures and 
serology (MHV, MPV, MVM, M.  pul., TMEV (GDVII), 
Ectro, EDIM, MAD1, MAD2, LCM, Reo-3). All tests were 
negative throughout the study.
Animal Husbandry, European Institute of Oncology
In addition to the study at UCD, life span studies were 
also completed on male and female ShcKO homozy-
gous, heterozygous and WT mice [129Sv, C57BL/6J 
and hybrid F1 C57BL/6J-129Sv strains] derived from 
the originally described ShcKO mice (3) at the European 
Institute of Oncology (EIO). The mice were housed in a 
SPF (FELASA) vivarium at the EIO. The mice were main-
tained in rooms with a 12-hour light/12-hour dark cycle at 
22°C ± 2°C and 55% ± 10% relative humidity. The mice 
were allowed continuous access to water and Teklad 2018S 
diet (Harlan Teklad, Bresso-Milan, Italy). The mice were 
singly housed starting at 8 weeks of age. Health checks 
were completed on the mice at least once per day. No pro-
cedures were completed on the mice, and the mice were 
only euthanized if they were moribund. The same criteria 
for euthanasia at UCD (described above) were followed 
at EIO. Life span was determined from the recorded date 
of death for each animal. All experiments were performed 
according to the European guidelines for the use of ani-
mals in research and the requirements of Italian laws and 
regulations.
Sentinel mice were housed in the same rooms as the 
study animals and were exposed to bedding from the study 
animals. Sentinels were euthanized every 2  months and 
underwent the same health screens as the mice at UCD. 
The facility was included in a health-monitoring program 
developed in accordance with the Federation of European 
Laboratory Animal Science Associations (FELASA) guide-
lines (9). All tests were negative during the study.
Pathology
For all the UCD animals, a gross necropsy was per-
formed, and a standardized set of tissues and lesioned 
organs were processed for histologic examination. These tis-
sues included liver, kidneys, spleen, pancreas, heart, lungs, 
thymus, gastrointestinal tract (esophagus, stomach, small 
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tract (testes, epididymis, prostate glands, and seminal vesi-
cles), haired skin, and skeletal muscle. Other tissues were 
submitted for examination on the basis of the presence of 
gross lesions at the time of necropsy. Formalin-fixed tissues 
were processed and embedded in paraffin by routine meth-
ods. Tissues were sectioned at 5 μm and stained with hema-
toxylin and eosin. Histologic examination was performed 
by STL, AK, and SMG.
Statistical Analysis
Maximum and mean body weights of WT and ShcKO 
mice in each diet group were compared using two-sample 
t-tests. Two-sample proportion tests were used to compare 
the incidence of cancer or organ pathology between geno-
types and diet groups.
To compare overall survival, survival curves for each 
genotype and diet group were estimated with Kaplan-
Meier estimators. A log rank test was used to test for dif-
ferences in survival among the four genotype and diet 
groups and to conduct all pairwise comparisons of the 
groups. A Bonferroni adjustment was used to maintain the 
family-wise error rate at 0.05 for the pairwise comparisons. 
Because no survival times were censored, survival times 
were also directly compared between the groups. For this 
analysis, Sprent’s nonparametric method for testing whether 
two distributions have the same median was generalized 
to test whether specified percentiles (10th through 90th) 
of survival times differed between groups (10). Finally, a 
Cox proportional hazard model was used to evaluate the 
effects of diet and genotype on survival, while adjusting 
for body weight. First, body weight was incorporated as 
a time-invariant predictor by using the mean and maxi-
mum body weight in two separate analyses. Second, mean 
weekly body weight was included as a time-varying predic-
tor. For this analysis, because age at death was recorded in 
days, while body weight was recorded weekly, weekly body 
weights were converted to daily values as follows. The last 
recorded weight was used as the weight at the time of death 
(i.e., the last value was carried forward). While most mice 
had weights recorded at the beginning of the week of their 
death, for some mice the last reported weights were 1 or 2 
weeks prior. Daily weights between weekly weights were 
imputed using linear interpolation.
Results
Body Weight
Weekly body weights for the UCD mice are shown in 
Figure  1. As expected, body weight was decreased (p < 
.001) in the 40% CR compared with 5% CR groups. At 40% 
CR, there was no difference between genotypes in mean 
lifetime body weight or maximum body weight (Table 1). 
In contrast, mean lifetime body weight and maximum body 
weight were increased (p < .01) in the WT compared with 
ShcKO mice at 5% CR (Table 1).
Longevity
The survival curves for the UCD mice are shown in 
Figure 2. There were no differences in the survival curves 
between the 5% CR WT and the ShcKO groups. Median 
and 10th percent survival for both groups were approxi-
mately 955 days and 1100 days, respectively (Table 2). As 
expected, median and 10th percent survival were increased 
(p < .05) in the 40% CR groups compared with either the 
5% CR WT or ShcKO groups. With 40% CR, there was an 
increase (p < .05) in 70th percentile survival in the ShcKO 
compared with WT mice (Table  2). However, this differ-
ence between ShcKO and WT groups had disappeared by 
the 50th percent survival point, and no further differences 
between genotypes were observed for the remaining sur-
vival statistics.
Figure 1. Mean body weights in wild-type (WT) and ShcKO C57BL/6J mice at UC Davis maintained on 5% or 40% calorie-restricted (CR) diets. All mice were 
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To investigate whether differences in body weight 
between the 5% CR WT and ShcKO mice influenced life 
span, body weight (average weekly weight, maximum 
weight or average body weight across the life span) was 
included as a covariate in a Cox proportional hazard model 
(11). Survival did not differ significantly (p > .10) between 
genotypes on the 5% CR diet with inclusion of any measure 
of body weight as a covariate.
In the studies at the EIO, there were no differences in 
combined male and female survival curves for ShcKO and 
WT mice on C57BL/6J (Figure 3), 129Sv (Figure 4) and 
hybrid F1 C57BL/6J x 129Sv (Supplemental Figure  2) 
backgrounds. When the survival curves were separated by 
sex, there was an increase (p < .05) in life span in WT ver-
sus ShcKO males on a 129Sv background (Figure 4B) and 
there was an increase (p < .05) in life span in Shc heterozy-
gous versus WT females on a hybrid F1 C57BL/6J x 129Sv 
background (Supplemental Figure 2C). However, it should 
be noted that there were only a small number of Shc het-
erozygous (n = 16) and WT (n = 18) females on the hybrid 
F1 background, and thus, these results should be viewed 
with caution. There were no other differences between either 
male or female ShcKO and WT mice.
Pathology
The necropsy results for the four groups of mice are 
summarized in Tables 3 and 4. The most frequent cause of 
death in this study was hepatic histiocytic sarcoma, which 
occurred in 75 of the 199 animals examined (Table  3). 
Typically neoplastic histiocytes expanded the sinusoids 
resulting in attenuation and necrosis of extensive regions 
of hepatic parenchyma. Metastasis was noted most fre-
quently to the spleen (n  =  29), lung (n  =  16), kidney 
(n = 8), and local lymph nodes (n = 6). An additional 33 
animals had evidence of marked Kupffer cell hyperpla-
sia. Kupffer cells are presumed to be the cell of origin of 
hepatic histiocytic sarcomas, and Kupffer cell hyperplasia 
was interpreted as a preneoplastic lesion. Other neoplasms 
were much less frequent and included lymphoma (n = 16), 
most commonly a multicentric process, hemangiosarcoma 
(n = 6), which typically arose from the spleen, and pul-
monary adenomas (n = 17). Lymphoid depletion (n = 28) 
and expansion of extramedullary hematopoiesis (n = 29) 
in the spleen were frequently seen as reactive/secondary 
changes to other pathology. Other common, age-related 
and incidental findings were degeneration and atrophy of 
the seminiferous tubules of the testicles (n = 82), ectasia 
Table 1. Effect of Calorie Restriction and ShcKO on Maximum Body Weight and Body Weight Averaged Across the Life Span*
5% CR WT 5% CR ShcKO 40% CR WT 40% CR ShcKO
Maximum body weight (g) 38.37 ± 4.45† 34.17 ± 4.38‡ 27.90 ± 4.32§ 27.46 ± 2.88§
Average body weight (g) 32.20 ± 2.91† 29.65 ± 3.12‡ 22.71 ± 1.23§ 22.60 ± 1.24§
Notes: *All body weight calculations used values collected after 20 weeks of age (this excludes the period of major weight loss following initiation of calorie 
restriction). Values within a row that contain different superscripts differ (p < .05).
5% CR WT = 5% calorie-restricted wild-type; 5% CR ShcKO  =  5% calorie-restricted ShcKO; 40% CR WT  =  40% calorie-restricted wild-type; 40% CR 
ShcKO = 40% calorie-restricted ShcKO.
Figure 2. Survival curves for wild-type (WT) and ShcKO C57BL/6J mice maintained on 5% or 40% calorie-restricted (CR) diets. All mice were housed at UC 
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and inspissation of the seminal vesicles (n  =  21), and 
mineralization of the vessels of the thalamus (n  =  23). 
There was no evidence of infectious pathogenic agents in 
any of the mice.
Statistical comparisons between the four groups were 
limited to broad categories (cancer incidence or overall 
presence of pathology within a specific organ), since the 
low frequency of specific pathology findings prevented 
more refined comparisons. There were no significant dif-
ferences in cancer incidence between any of the groups of 
mice. The only significant difference between ShcKO and 
WT mice was a decrease in gastrointestinal pathology in 
the 5% CR ShcKO compared with WT mice. This primarily 
reflected the fact that there was a greater incidence of small 
intestine amyloidosis in the WT (14%) compared with the 
ShcKO (2%) mice.
The end-of-life pathology was similar between the 5% 
and 40% CR groups (Table  4), except there were clear 
decreases in dilation of seminal vesicles and ectasia and 
inspissations in the 40% versus 5% CR mice. In contrast, 
the incidence of testicular degeneration was increased in the 
40% CR compared with 5% CR groups.
Table 2. Life Span Statistics for Wild-type and ShcKO Mice*
5% CR WT 5% CR ShcKO 40% CR WT 40% CR ShcKO
70th percentile 879† (828, 930) 867† (805, 929) 1002‡ (931, 1073) 1082§ (1035, 1129)
50th percentile 956† (915, 997) 953† (904, 1002) 1111‡ (984, 1238) 1153‡ (1128, 1178)
30th percentile 1012† (967, 1057) 1034† (967, 1101) 1202‡ (1153, 1251) 1212‡ (1178, 1246)
10th percentile 1099† (1080, 1118) 1111† (1085, 1137) 1322‡ (1291, 1353) 1287‡ (1232, 1342)
Longest lived 1246 1241 1447 1335
Notes: *Survival times (days) with approximate 95% confidence interval indicated in parenthesis. Values in a row that contain different superscripts differ at 
p < .05 determined by Sprent’s nonparametric method.
5% CR WT = 5% calorie-restricted wild-type; 5% CR ShcKO  =  5% calorie-restricted ShcKO; 40% CR WT  =  40% calorie-restricted wild-type; 40% CR 
ShcKO = 40% calorie-restricted ShcKO.
Figure 3. Survival curves for wild-type (WT) and ShcKO C57BL/6J mice fed ad libitum. All mice were housed at the European Institute of Oncology. (A) Male 
and female mice, (B) male mice only, (C) female mice only (n = 28 WT males, n = 28 ShcKO males, n = 39 WT females, n = 36 ShcKO females).
Figure 4. Survival curves for wild-type (WT) and ShcKO 129Sv mice fed ad libitum. All mice were housed at the European Institute of Oncology. (A) Male and 
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Table 4. Pathology at Time of Death in Control and Calorie-restricted Mice
5% CR WT (n = 49) 5% CR ShcKO (n = 49) 40% CR WT (n = 50) 40% CR ShcKO (n = 49)
Liver
 Histiocytic sarcoma 17 16 20 19
 Kuppfercell hyperplasia 7 4 7 15
 Extramedullary hematopoiesis 11 5 5 4
 Hepatocellular degeneration 4 3 2 2
 Lymphohistiocytic hepatitis 4 2 3 2
 Lymphoma 3 3 0 1
 Hemangiosarcoma 0 1 3 0
Reproductive
 Testes
  Seminiferous tubule atrophy and degeneration 14 14 24 30
 Seminal vesicles
  Presence of eosinophilic secretory material 17 23 1 2
  Dilation of 15 21 1 2
  Ectasia and inspissation 4 11 3 3
 Prostate
  Prostatitis 0 2 0 2
Spleen
 Extramedullary hematopoiesis 4 7 12 6
 Histiocytic sarcoma 8 7 5 9
 Lymphoid depletion 11 4 8 5
 Hemangiosarcoma 2 1 1 0
 Hemosiderosis 0 0 3 0
 Lymphoma 1 1 1 0
Kidney
 Lymphoplasmacytic interstitial nephritis 13 10 14 12
 Tubular mineralization 9 3 7 7
 Hyaline droplet nephropathy 6 6 6 2
 Hydronephrosis 3 4 3 1
 Histiocytic sarcoma 3 2 0 3
 Glomerular sclerosis 3 1 2 1
 Lymphoma 1 1 2 1
 Tubular cyst 3 0 0 2
 Tubular degeneration 0 1 0 3
 Lymphocytic infiltrates 0 0 0 1
Lung
 Histiocytic sarcoma 5 6 5 5
 Pulmonary adenoma 4 5 3 5
 Pneumonia 1 6 4 5
 Lymphoma 2 0 3 0
 Pulmonary carcinoma 0 2 1 0
 Lymphocytic leukemia 1 1 0 0
 Pulmonary carcinoma 0 0 1 0
Heart 
 Ventricular dilation 1 3 6 8
 Aortic mineralization 0 1 2 2
 Ventricular thrombosis 0 1 1 3
 Atrial thrombosis 0 2 0 2
 Atrial dilation 1 0 0 2
Table 3. Prevalence of Neoplasms in Wild-type and ShcKO Mice
Neoplasm 5% CR WT (n = 49) 5% CR ShcKO (n = 49) 40% CR WT (n = 50) 40% CR ShcKO (n = 49)
Histiocytic sarcoma 17 16 19 23
Lymphoma 5 6 4 1
Other 6 8 4 5
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Discussion
The results of the present study indicate that ShcKO 
does not increase median or maximum life span in mice, 
and therefore, Shc is not a longevity gene. These conclu-
sions conflict with a previous study that found that life span 
was increased by 30% in ShcKO compared with WT mice 
(3). There are at least three differences between the studies, 
which could contribute to the disparate life span results.
Strain Differences
The strains of mice used in the life span studies could 
influence the results. As a first step toward determining 
whether the strain could play a role in the life span dif-
ferences between studies, it is important to determine if 
the life span values of the WT animals are consistent with 
published values for their strain. The median life span of 
the mice used in the present study met or exceeded typi-
cal life span values for C57BL/6 mice (12–15). In con-
trast, the median survival (761 days) of the WT mice in 
the study by Migliaccio et al. was below median life span 
values for male and female 129 mice maintained in a spe-
cific-pathogen free facility (14). The increase in life span 
observed in the study by Migliaccio et al. may primarily 
be a result of rescue of whatever stress was causing the 
low life span of the WT mice used in this study, and there 
is considerable evidence that Shc deficiency promotes 
stress resistance (7,16–18). To further test the influence of 
mouse strain on longevity of ShcKO mice, life span meas-
urements were completed on C57BL/6J and 129Sv WT 
and ShcKO mice at the EIO. Life span was not increased 
in the ShcKO mice regardless of the mouse strain. Thus, 
mouse strain is not responsible for the differences in life 
span between studies.
5% CR WT (n = 49) 5% CR ShcKO (n = 49) 40% CR WT (n = 50) 40% CR ShcKO (n = 49)
 Endocardial mineralization 1 2 0 0
 Myocardial fibrosis 0 1 0 2
 Myocardial degeneration 0 0 2 0
 Aortic valvular thrombosis 1 0 0 0
 Myocardial mineralization 0 0 1 0
 Pericardial mineralization 0 0 1 0
Gastrointestinal/urinary tract
 Large Intestine
  Vessel congestion 1 1 0 0
  Edema 0 0 1 0
  Epithelial necrosis 1 0 0 0
  Lymphoplasmacytic colitis 0 0 1 0
  Mucosal necrosis 1 0 0 0
 Small Intestine
  Amyloidosis 7 1 2 0
  Chronic intraluminal hemorrhage 0 0 0 2
  Lymphoplasmacytic enteritis 0 0 2 0
  Chronic hemorrhage 0 0 0 1
  Epithelial necrosis 1 0 0 0
 Stomach
  Gastritis 2 1 2 1
  Amyloidosis 1 1 0 0
  Anaplastic sarcoma 1 0 0 1
 Mesentery
  Lymphoma 0 0 1 0
 Ureter
  Hydroureter 1 0 0 0
 Urethra
  Urethritis 1 0 0 1
  Subepithelial hemorrhage 0 0 0 1
Brain
 Mineralization (Thalamus) 3 6 6 8
 Histiocytic sarcoma 0 0 1 0
 Meninges lymphoma 1 0 0 0
Lymph nodes
 Histiocytic sarcoma 1 1 1 3
 Lymphadenitis 2 1 1 1
 Lymphoma 2 1 1 0
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Differences in Mouse Numbers
A second possible reason for differences between the 
studies is that they used different numbers of mice, with 
49–50 mice per group in the present UCD study and 
14–15 mice per group in the 1999 study. A concern with 
the use of 15 (or fewer) mice per group is the fact that 
each animal has a large impact on the survival curve. It 
can be difficult to reproduce these studies which are so 
heavily influenced by a few animals, and thus, a larger 
sample size is needed to allow for random fluctuations 
about the true life span trend in finite-sample experi-
ments. It has been recommended that life span studies 
include 40–50 mice per group to avoid excessive influ-
ence of individual animals on survival curves, provide 
adequate power to detect differences between groups 
of mice and allow more detailed statistical analysis of 
survival curves (19). It is possible that the increase in 
life span in the ShcKO group in the previous study was 
an anomaly resulting from the small number of animals 
used in the study.
Differences in Animal Husbandry
The third potential reason for the difference between 
studies is differences in animal husbandry. One area of 
possible difference is level of food intake. The mice in the 
present UCD study were fed a mildly (5%) restricted diet. 
However, it seems unlikely that this had a major influ-
ence on the results, since the body weights of the mice 
in both studies were similar and there was no evidence 
of obesity being a factor in either study. Furthermore, 
there were no differences in longevity between WT and 
ShcKO in the studies at the EIO using ad libitum fed 
animals. The relatively low life span of the WT group in 
the previous study (3) strongly suggests that husbandry 
for these animals was not ideal, and the observed results 
represent a response to some level of environmental 
stress. It is possible that ShcKO will improve survival in 
response to some stressors. However, it is important to 
note that another study found that life span is decreased 
in ShcKO compared with WT mice when housed in an 
outdoor enclosure intended to mimic a natural environ-
ment (20). It has also been reported that p66Shc levels 
are higher in fibroblasts from centenarians compared to 
elderly (50–80 years) or young (17–38 years) people (21). 
These results suggest that chronic decreases in p66Shc 
levels, at least in one cell type, are not required for a long 
life. It remains to be determined which specific environ-
mental conditions may alter survival in animals with low 
Shc levels. Nonetheless, the results of the present study 
indicate that life span is not increased in ShcKO mice 
when compared with WT animals, which meet expected 
life span values for their strains under the highest hus-
bandry standards. Thus, these results indicate that Shc is 
not a life span gene.
Shc Deficiency, Calorie Restriction, and Health Span
A secondary goal of the present study was to determine 
whether ShcKO influences life span in 40% CR mice. 
The results of the study showed that 70th percentile sur-
vival was significantly increased in the 40% CR ShcKO 
compared with WT mice, while median life span and sub-
sequent survival statistics were not different between the 
genotypes. These results indicate that ShcKO had an influ-
ence on disease processes that resulted in early death in the 
40% CR mice but had no influence on rate of aging. Shc 
proteins have been shown to play a role in energy metabo-
lism (6,8,22–25) and reactive oxygen species production 
(2,26,27), and it is likely that these actions of Shc proteins 
could influence some age-related diseases and possibly alter 
life span under certain conditions. In particular, ShcKO 
mice have increased insulin sensitivity (6) and are resist-
ant to ischemic injury (28), atherosclerosis (26) and apop-
tosis induced by a variety of stressors (17). These effects 
of ShcKO would be expected to have a positive influence 
on health span even if life span is not lengthened. There 
is also evidence that ShcKO decreases adiposity (6,22,25) 
and increases capacity for fatty acid oxidation (8) and these 
changes may influence life span under certain conditions, 
such as diet-induced obesity. Consistent with this idea, it 
has been reported that life span is increased in obese, leptin 
deficient mice (ob/ob) on a ShcKO versus WT background 
(25). The influence of ShcKO on age-related disease and 
health span with various diets and models of obesity is an 
area that warrants further investigation.
Shc Deficiency and End-of-Life Pathology
Similar to previous studies in C57BL/6 mice (12,29), 
neoplastic disease was the primary cause of death with his-
tiocytic sarcoma and lymphomas as the major neoplasms. 
There was no difference in prevalence of neoplasms or other 
measures of end-of-life pathology between the ShcKO and 
WT mice. Although there is considerable interest in the role 
Shc proteins play in tumorigenesis (18), the results of the 
present study indicate that the decreased level of Shc pro-
teins in the ShcKO mice had no influence on the occurrence 
of neoplasia. A clear limitation of the present study, how-
ever, was the fact that only end-of-life pathology was meas-
ured, and it was not possible to determine whether ShcKO 
or level of restriction influenced the age of onset of any of 
the measures of pathology. Although knockdown of Shc pro-
teins had little influence on end-of-life pathology in either 
5% or 40% CR mice, additional studies are needed to deter-
mine if Shc proteins influence the onset or duration of major 
age-related diseases. Another limitation of the present study 
is the fact that C57BL/6 mice die primarily from neoplasms 
(in particular lymphomas and histiocytic sarcomas). Further 
studies are needed to determine if ShcKO influences pathol-
ogy in animal models that die primarily from causes other 
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Conclusions
The results of the present study indicate that median and 
maximum life spans are not increased in ShcKO compared 
with WT mice. Thus, Shc is not a life span gene. However, 
ShcKO did increase survival time in the first portion (70th 
percentile) of the survival curve in 40% CR mice. This indi-
cates that ShcKO does have an influence on some disease 
processes. Shc proteins play a role in insulin signaling, stress 
resistance, and energy metabolism, and additional studies 
are needed to determine the extent to which these actions of 
Shc proteins influence health span and age-related changes 
in physiological function and disease.
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